Speech recognition with the MPEAK and SPEAK speech-coding strategies of the Nucleus Cochlear Implant.
Where this comes from
- Record sourced from PubMed, PMID 9051058.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Spectra 22 Speech Processor and spectral peak (SPEAK) speech-coding strategy provide Nucleus 22 Channel Cochlear Implant (Cochlear, Corp., Englewood, Colo.) users with a better understanding of speech than the previous Mini Speech Processor and Multipeak (MPEAK) speech-coding strategy. On the NU-6 Monosyllabic Word Test, subjects scored 13% higher for words and 14% higher for phonemes with the SPEAK strategy than with the MPEAK strategy. On the Connected Speech Test and the CID Everyday Sentence Test, subjects scored 32% and 37% higher, respectively, with SPEAK than with MPEAK.
Medical subject headings
- Cochlear Implants
- Communication Devices for People with Disabilities
- Deafness
- Speech Perception